eFFECTOR Therapeutics, Inc.

    eFFECTOR Therapeutics, Inc.

    NNASDAQ:EFTRW
    - -
    USD
    - -
    - -
    eFFECTOR Therapeutics, Inc.
    NASDAQ:EFTRW
    (Nasdaq Stock Market)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2020
    2021
    2022
    2023
    TTM
    USD
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    - -
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    - -
    - -
    - -
    - -
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    Basic Weighted Avg Shares
    42
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    37.66
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    14
    16
    -23
    -36
    -35
    Net Income, GAAP
    2.41
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    33.84
    - -
    - -
    - -
    - -
    Profit Margin (%)
    8
    49
    3
    -6
    1
    Working Capital
    7
    20
    - -
    - -
    - -
    LT Debt
    -132
    17
    4
    -6
    1
    Total Equity
    - -
    78.5
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    -15.64
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    ST Debt
    20
    21
    20
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    2
    3
    4
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    Total Current Assets
    19
    20
    26
    Cash, Cash Equivalents & STI
    18
    18
    25
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    24
    26
    26
    Payables & Accruals
    2
    4
    5
    ST Debt
    20
    21
    20
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -248.74%
    Free Cash Flow
    - -
    - -
    13.63%
    Net Income, GAAP
    - -
    - -
    58%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business